Skip to main content

Our latest

  • Hyris signs a distribution agreement with GrowBIGogh

    Hyris signed a distribution agreement with GrowBIGogh a a company selling technology solutions for hydroponics and farming industries, based in Gilroy & Salinas, CA.

  • Hyris technology supports the fight against one of the world’s deadliest diseases, malaria.

    Climate change and global warming greatly boost viral outbreaks, as confirmed in a scientific study, highlighting the need for better pandemic readiness and disease surveillance.

  • Hyris fulfils its integration into Ulisse Biomed to give birth to a new international group ready to make its mark in the global biotech market.

    A new international biotech group was born from the integration of Hyris Ltd, renowned worldwide for its disruptive genetic testing platform, and Ulisse Biomed S.p.A., also known as UBM Group or “UBM” only, a leading Italian-based publicly traded biotech company appreciated for its innovative testing platforms.

  • Distribution agreement renewal with Biomol Laboratories, fostering the partnership in the field of personalised medicine

    Hyris has renewed its distribution agreement for the products of Biomol Laboratories, an innovative company in the field of medical biotechnology, specialized in the design and production of in vitro medical devices in the analytical lines of Genetics, Pharmacogenetics and Oncohematology.